Spdm - Associacao Paulista Para O Desenvolvimento DA Medicina

Spdm - Associacao Paulista Para O Desenvolvimento DA Medicina (operating as Hospital SAO Paulo), a tax-exempt Brazilian hospital entity, functions exclusively as a sub-recipient on federal research grants focused on pulmonary and infectious-disease clinical research, with no prime federal contracts or grants in its footprint.

Hospital SAO Paulo is a non-profit organization headquartered in São Paulo, Brazil (R. Napoleão de Barros, 715 - Vila Clementino), structured as a tax-exempt corporate entity. The vendor operates entirely in a sub-award capacity on NIH-funded research grants issued through University of California, San Francisco as prime grantee. All three sub-awards in the source data are with the same prime grantee, reflecting a focused, single-relationship posture.

The vendor's federal grant work centers on clinical research in pulmonary arterial hypertension (PAH) and related vascular disease. Two grants (awarded December 2023) address systemic sclerosis-associated PAH and schistosomiasis-associated PAH, respectively; both are funded by the National Institutes of Health National Heart Lung and Blood Institute and executed through UCSF. The work involves patient screening and enrollment, biospecimen collection (blood sampling via invasive pulmonary hemodynamic assessment), REDCap database development and maintenance, and support for clinical research activities at the Federal University of São Paulo (UNIFESP) site where Hospital SAO Paulo's clinical staff operate. A third sub-award (January 2025) is noted as a continuation with no scope change. Combined dollars obligated across all three awards total $245 thousand over the source period (December 2023 through January 2025). The customer base comprises two agencies: the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute (one award) and the Department of the Army Medical Command (two awards).

The vendor's role is anchored in clinical research delivery and patient cohort support rather than prime grant management or federal contracting. Activity remains sparse — one award per year on average — with no indication of vehicle participation, teaming arrangements beyond its UCSF primary relationship, or pursuit of prime award eligibility.